Qube Research & Technologies LTD Caribou Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.62 - $5.05 $356,427 - $1.11 Million	220,017 New	220,017 $360,000
Q2 2023 Aug 14, 2023	BUY	$4.04 - $5.47 $337,792 - $457,357	83,612 New	83,612 $355,000
Q4 2022 Feb 14, 2023	BUY	$5.57 - $11.01 $133,819 - $264,515	24,025 New	24,025 $150,000
Q2 2022 Aug 15, 2022	SELL	$5.1 - $9.74 $183,253 - $349,977	-35,932 Reduced 71.5%	14,326 $78,000
Q1 2022 May 09, 2022	BUY	$8.42 - $15.32 $423,172 - $769,952	50,258 New	50,258 $461,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.